Review: taking Clopidogrel and Ubiquinone together


Summary

Drug interactions are reported among people who take Clopidogrel and Ubiquinone together. This review analyzes the effectiveness and drug interactions between Clopidogrel and Ubiquinone. It is created by eHealthMe based on reports of 38 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Clopidogrel and Ubiquinone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Clopidogrel

Clopidogrel has active ingredients of clopidogrel. It is often used in antiplatelet therapy. (latest outcomes from Clopidogrel 13,688 users)

Ubiquinone

Ubiquinone has active ingredients of coenzyme q - 10. It is often used in supplementation therapy. (latest outcomes from Ubiquinone 27 users)

On Aug, 27, 2016

38 people who take Clopidogrel, Ubiquinone are studied.


Number of reports submitted per year:

Clopidogrel and Ubiquinone drug interactions.

Drug effectiveness over time:

Clopidogrel:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Ubiquinone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Clopidogrel:
  • female: 0.0% - (0 of 1 people)
  • male: 25.0% - (1 of 4 people)
Ubiquinone:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 4 people)

Drug effectiveness by age:

Clopidogrel:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 33.0% - (1 of 3 people)
Ubiquinone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • depression
  • dizziness
  • rhabdomyolysis
  • weakness
1 - 6 months:
  • abdominal pain aggravated
  • depression
  • dizziness
  • high blood pressure
  • rhabdomyolysis
  • weakness
6 - 12 months:
  • heart mri
1 - 2 years:
  • abdominal pain aggravated
  • high blood pressure
5 - 10 years:
  • heart mri
not specified:
  • pain
  • myocardial infarction
  • dyspnoea
  • paraesthesia
  • weight decreased
  • weight increased
  • asthenia
  • blood cholesterol increased
  • myalgia
  • chest pain

Most common drug interactions by gender *:

female:
  • chest pain
  • weight increased
  • abdominal discomfort
  • abdominal pain aggravated
  • aphagia
  • blood glucose increased
  • blood potassium decreased
  • blood pressure decreased
  • blood sodium decreased
  • bone pain
male:
  • myocardial infarction
  • pain
  • dizziness
  • paraesthesia
  • asthenia
  • blood cholesterol increased
  • myalgia
  • dyspnoea
  • feeling hot
  • weight decreased

Most common drug interactions by age *:

10-19:
  • fall
  • gingival bleeding
  • soft tissue necrosis
  • weight increased
30-39:
  • depression
  • rhabdomyolysis
  • weakness
50-59:
  • dizziness
  • abdominal discomfort
  • abdominal distension
  • abdominal pain
  • acute myocardial infarction
  • atrial fibrillation
  • chest discomfort
  • chest pain
  • colon adenoma
  • colonic polyp
60+:
  • myocardial infarction
  • pain
  • weight decreased
  • asthenia
  • myalgia
  • dyspnoea
  • weight increased
  • blood cholesterol increased
  • limb discomfort
  • low density lipoprotein increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Clopidogrel and Ubiquinone?

Can you answer these questions?

More questions for: Clopidogrel, Ubiquinone

You may be interested in these reviews

More reviews for: Clopidogrel, Ubiquinone

On eHealthMe, Clopidogrel (clopidogrel) is often used to treat antiplatelet therapy. Ubiquinone (coenzyme q - 10) is often used to treat supplementation therapy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.